Category: Business of health

12/19/2017

A veteran journalist explains why it’s so tough to inform the public about medical devices — and what can be done about it

11/22/2017

Not so fast: News headlines claiming two therapies were proven ‘equally effective’ for treating opioid use disorder

6 10/26/2017

Hospitals and doctors: Is their role in soaring health care costs overlooked?

1 10/25/2017

Why health claims about essential oils deserve more scrutiny from journalists

10/18/2017

More evidence that women should be wary of ‘ovarian reserve testing’ events

3 9/26/2017

A prostate ‘Pep Talk’ is the wrong way to get men thinking about cancer screening

6 9/5/2017

Facts about the new ALS drug Radicava that you’re unlikely to see in news stories

1 9/1/2017

A $475,000 cancer drug: Wall Street sees ‘bargain’; patients see ‘completely broken’ system

8/16/2017

Investors aren’t the only ones burned by misleading drug company news releases

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

National Breast Cancer Coalition @NBCCStopBC·

A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold

Reply on Twitter 1520768892888567810 Retweet on Twitter 15207688928885678101 Like on Twitter 15207688928885678103 Twitter 1520768892888567810

HealthNewsReview.org @HealthNewsRevu·

Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's ⁦@CarlaKJohnson⁩. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d

Reply on Twitter 1516522980385472513 Retweet on Twitter 1516522980385472513 Like on Twitter 15165229803854725134 Twitter 1516522980385472513